论文部分内容阅读
目的 探讨疤痕子宫孕妇中期妊娠引产的安全性。方法 疤痕组 11例 ,采用口服米非司酮 2 5mg每日 2次 (总量 15 0mg) ,服药第 2d利凡诺羊膜腔内注射 10 0mg。正常同期引产 2 0例做对照组。 结果 两组中期妊娠引产的病人用药至宫缩开始的时间差异无显著意义 (P >0 0 5 ) ,疤痕组在分娩、引产的出血量、并发症等方面与正常的中期妊娠引产相比较 ,其差异无显著意义 (P >0 0 5 )。结论 即便是疤痕子宫的孕妇 ,再次妊娠而不能生育时也可以安全地进行中期妊娠引产。
Objective To investigate the safety of induction of labor during mid-term pregnancy in scar uterus. Methods 11 cases of scar group were treated with oral mifepristone 25mg twice a day (total 150mg). 20 cases of normal induction of labor as the control group. Results There was no significant difference in the time between the initiation of contractions and the induction of labor in the second trimester of pregnancy (P> 0.05). Compared with the normal middle-term pregnancy induction of labor in the scar group in delivery, the amount of bleeding induced by labor and the complications, The difference was not significant (P> 0.05). Conclusions Even pregnant women with a scar of the uterus can safely carry out mid-term pregnancy induction of labor when they can not give birth again.